This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Effects of VLCKD in Metabolic Syndrome | MicrobiomeTrials
← Back to trials NCT05275608
Effects of VLCKD in Metabolic Syndrome Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2022-11-07Est. Completion: 2026-01-31
Enrollment target: 40 participantsLocations : Italy Pediatric Endocrine Service of AOU Maggiore della Carità of Novara; SCDU of Pediatrics, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy, Italy Other microbiome trials you might be interested in Type 2 Diabetes Mellitus (T2DM)
This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…
Siirt, Turkey (Türkiye) Est. completion Jul 15, 2027
Type 1 Diabetes (T1D)
Islet transplantation restores glucose tolerance in people living with diabetes characterised by high glycaemic variabil…
Strasbourg, France Est. completion Jan 2032
Cardiometabolic Risk Factors Mental Health
Background:
As of 2021, almost 45 million people in the United States were foreign-born immigrants. South Asians, inclu…
Columbus, United States Est. completion Aug 31, 2027